Published in
Taylor and Francis Group, Leukemia & Lymphoma, 3-4(16), p. 335-342, 1995
DOI: 10.3109/10428199509049773
Links
Tools
Recombinant Interferon α2a, Thymopentin and Low Doses of Cytosine Arabinoside for the Treatment of Myelodysplastic Syndromes: A Pilot Study
Journal article published in 1995 by
Adriano Venditti 
,
Maria Teresa Scimo,
Giovanni Del Poeta,
Francesco Buccisano ,
Roberto Stasi,
Antonio Mastino,
Sandro Grelli ,
Cartesio Favalli,
Enrico Garaci,
Giuseppe Papa
,
Maria Teresa Scimo,
Giovanni Del Poeta,
Francesco Buccisano ,
Roberto Stasi,
Antonio Mastino,
Sandro Grelli ,
Cartesio Favalli,
Enrico Garaci,
Giuseppe Papa
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 